367 related articles for article (PubMed ID: 31727136)
1. The diagnostic value of soluble urokinase-type plasminogen activator receptor (suPAR) for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine.
Scharrenberg JS; Yagdiran A; Brinkmann J; Brune M; Siewe J; Jung N; Mahabir E
J Orthop Surg Res; 2019 Nov; 14(1):367. PubMed ID: 31727136
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic value of soluble urokinase plasminogen activator receptor (suPAR) compared to C-reactive protein (CRP) and procalcitonin (PCT) in children with systemic inflammatory response syndrome (SIRS).
Şirinoğlu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Yalındağ-Öztürk N; Cinel İ; Yaman A; Haklar G; Şirikci Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
J Infect Chemother; 2017 Jan; 23(1):17-22. PubMed ID: 27771157
[TBL] [Abstract][Full Text] [Related]
3. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of cytokines for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine.
Brinkmann J; Zeißler EC; Scharrenberg JS; Schenk J; Majjouti M; Oberste M; Yagdiran A; Scheyerer MJ; Jung N; Siewe J; Mahabir E
Cytokine; 2022 Feb; 150():155782. PubMed ID: 34933239
[TBL] [Abstract][Full Text] [Related]
5. suPAR as a marker of infection in acute kidney injury - a prospective observational study.
Hall A; Crichton S; Varrier M; Bear DE; Ostermann M
BMC Nephrol; 2018 Aug; 19(1):191. PubMed ID: 30071826
[TBL] [Abstract][Full Text] [Related]
6. Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late-onset Sepsis.
Okulu E; Arsan S; Akin IM; Ates C; Alan S; Kilic A; Atasay B
J Clin Lab Anal; 2015 Sep; 29(5):347-52. PubMed ID: 25043869
[TBL] [Abstract][Full Text] [Related]
7. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
[TBL] [Abstract][Full Text] [Related]
8. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
Gumus A; Altintas N; Cinarka H; Kirbas A; Hazıroglu M; Karatas M; Sahin U
Int J Chron Obstruct Pulmon Dis; 2015; 10():357-65. PubMed ID: 25709430
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome.
Hoenigl M; Raggam RB; Wagner J; Valentin T; Leitner E; Seeber K; Zollner-Schwetz I; Krammer W; Prüller F; Grisold AJ; Krause R
Clin Biochem; 2013 Feb; 46(3):225-9. PubMed ID: 23159293
[TBL] [Abstract][Full Text] [Related]
10. Can soluble urokinase plasminogen receptor predict outcomes after cardiac surgery?
Schultz-Swarthfigure CT; McCall P; Docking R; Galley HF; Shelley B
Interact Cardiovasc Thorac Surg; 2021 Jan; 32(2):236-243. PubMed ID: 33236082
[TBL] [Abstract][Full Text] [Related]
11. Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects.
Sørensen MH; Gerke O; Eugen-Olsen J; Munkholm H; Lambrechtsen J; Sand NP; Mickley H; Rasmussen LM; Olsen MH; Diederichsen A
Atherosclerosis; 2014 Nov; 237(1):60-6. PubMed ID: 25222341
[TBL] [Abstract][Full Text] [Related]
12. The role of soluble urokinase plasminogen activator receptor (suPAR) in the diagnostics of diabetic foot infection.
Aslan S; Demirdal T; Erbak H; Aslan C
Infect Dis (Lond); 2020 Feb; 52(2):107-113. PubMed ID: 31713451
[No Abstract] [Full Text] [Related]
13. Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.
Hayek SS; Divers J; Raad M; Xu J; Bowden DW; Tracy M; Reiser J; Freedman BI
J Am Heart Assoc; 2018 May; 7(9):. PubMed ID: 29716888
[TBL] [Abstract][Full Text] [Related]
14. Soluble Urokinase Plasminogen Activator Receptor: A New Biomarker in the Pediatric Intensive Care Unit.
El-Mekkawy MS; Saleh NY; Sonbol AA
Indian J Pediatr; 2016 Jul; 83(7):661-9. PubMed ID: 26960717
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of soluble urokinase plasminogen activator receptor compared with C-reactive protein and procalcitonin in children with febrile neutropenia.
Sirinoglu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Cinel I; Koç A; Tokuç G; Yaman A; Haklar G; Şirikçi Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
Pediatr Hematol Oncol; 2016 Apr; 33(3):200-8. PubMed ID: 27057782
[TBL] [Abstract][Full Text] [Related]
16. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments.
Alstrup M; Meyer J; Schultz M; Rasmussen LJH; Rasmussen LS; Køber L; Forberg JL; Eugen-Olsen J; Iversen K
World J Surg; 2019 Mar; 43(3):780-790. PubMed ID: 30390135
[TBL] [Abstract][Full Text] [Related]
17. The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis.
Huang F; Li Y; Xu R; Cheng A; Lv Y; Liu Q
Mediators Inflamm; 2020; 2020():7850179. PubMed ID: 32322165
[TBL] [Abstract][Full Text] [Related]
18. Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus.
Toldi G; Szalay B; Bekő G; Bocskai M; Deák M; Kovács L; Vásárhelyi B; Balog A
Biomarkers; 2012 Dec; 17(8):758-63. PubMed ID: 23033975
[TBL] [Abstract][Full Text] [Related]
19. Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation.
Koh AS; Velmurugan B; Gao F; Tan RS; Wong JI; Teo LLY; Keng BMH; Chua SJM; Yuan JM; Koh WP; Cheung C
BMC Geriatr; 2017 Nov; 17(1):275. PubMed ID: 29179674
[TBL] [Abstract][Full Text] [Related]
20. Could soluble urokinase plasminogen receptor (suPAR) be used as a diagnostic biomarker for ventilator-associated pneumonia?
Sunnetcioglu A; Sunnetcioglu M; Adıyaman F; Binici I; Soyoral L
Clin Respir J; 2017 Nov; 11(6):925-930. PubMed ID: 26683264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]